drugset / Trial / NCT02317276

A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

NCT02317276

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the differential expression of AD biomarkers in serum, plasma, and skin biopsies from both lesional and non-lesional skin in moderate to severe AD patients in the presence of TCS and after withdrawal from TCS.

Timeline

Start
2014-12
Primary completion
2017-04-06
Completion
2017-04-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Other / unclassified 0.1 % Topical

Indications